News

Newsletter

November 22, 2022

New decision from the Brazilian Supreme Court in favor of Patent Term Adjustment (PTA) cases

A new decision from the Brazilian Supreme Court on November 16th brought some hope to patent owners seeking the term adjustment for patents New decision from the Brazilian Supreme Court in favor of Patent Term Adjustment (PTA) cases

Ler notícia

November 14, 2022

Brazilian Data Protection Authority publishes its 2023-2024 Regulatory Agenda

On November 8, 2022, the Brazilian Data Protection Authority (“Authority”) published its 2023-2024 Regulatory Agenda (“Current Agenda”), establishing high-priority topics over the Brazilian Data Protection Authority publishes its 2023-2024 Regulatory Agenda

Ler notícia

November 10, 2022

Bill creates Legal Framework for the Electronic Games Industry in Brazil

On October 19, 2022, the Brazilian House of Representatives approved Bill No. 2.796/2021 that creates a legal framework for the Brazilian gaming Bill creates Legal Framework for the Electronic Games Industry in Brazil

Ler notícia

October 20, 2022

CFM updates its Resolution on cannabidiol prescription and use

The Federal Council of Medicine (CFM) published, on 10/14/2022, CFM Resolution No. 2,324/22, which authorizes the use of cannabidiol (CBD) for treatment CFM updates its Resolution on cannabidiol prescription and use

  • ...
Ler notícia

October 14, 2022

Copyright registration in Brazil may now be submitted via online system

While registration is not mandatory in Brazil for copyright protection, it is a recommended measure as it may serve as evidence of Copyright registration in Brazil may now be submitted via online system

Ler notícia

September 28, 2022

ANVISA approves new Resolution RDC related to Medical Devices

ANVISA published, in the Federal Official Gazette, RDC No. 751/2022, which provides and defines, in relation to medical devices, the (i) risk classification rules; (ii) labeling ANVISA approves new Resolution RDC related to Medical Devices

  • ...
Ler notícia

August 16, 2022

Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

On August 8th, 2022, during the 12th Extraordinary Public Meeting of DICOL, ANVISA’s Collegiate Board of Directors announced the completion of the toxicological Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

  • ...
Ler notícia

July 19, 2022

Carbendazim toxicological revaluation about to be completed by ANVISA

In December 2019, ANVISA started the process of toxicological revaluation of the Active Ingredient (AI) Carbendazim, as signs of toxicity were identified Carbendazim toxicological revaluation about to be completed by ANVISA

  • ...
Ler notícia

July 6, 2022

Compulsory license: patent owners in Brazil are under no obligation to provide know-how and raw materials

Good news for patent owners in Brazil: the National Congress has upheld the President’s veto n° 48/2021, which prevented those who had their Compulsory license: patent owners in Brazil are under no obligation to provide know-how and raw materials

  • Kasznar Leonardos
  • Ler notícia

    June 21, 2022

    Provisional Measure Transforms the Brazilian Data Protection Authority into an Independent Entity

    Provisional Measure 1,124/22 published this past June 14, 2022, transformed the Brazilian Data Protection Authority into a special nature entity. The Measure is Provisional Measure Transforms the Brazilian Data Protection Authority into an Independent Entity

    Ler notícia

    June 6, 2022

    Brazilian PTOs opens public consultation on inventions related to transgenic plants

    On June 1, 2022, the public consultation of the BPTO’s Technical Note CPAPD nº 01/2022 was published in the Federal Official Gazette n° Brazilian PTOs opens public consultation on inventions related to transgenic plants

  • Kasznar Leonardos
  • Ler notícia
    plugins premium WordPress